Physician profile
Fima Macheret
NPI 1639468663
$12,028.05
in general payments reported to CMS, 2019-2025
8 companies · $8,774 in 2025
The $8,774 reported for 2025 was more than what 78% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $128 · 2023: $192 · 2024: $2,934 · 2025: $8,774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,225 · Travel and Lodging: $4,065 · Food and Beverage: $2,368 · Education: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,225.00 |
| Travel and Lodging | $4,065.43 |
| Food and Beverage | $2,368.44 |
| Education | $241.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $8,274.88 | 2024-2025 | Carto 3 |
| Abbott Laboratories | $2,403.99 | 2022-2025 | Aveir, Ensite, Ensite Precision |
| Medical Device Business Services, INC. | $619.21 | 2024 | Carto 3 |
| Boston Scientific Corporation | $402.09 | 2024-2025 | Resonate El Icd Vr, Watchman Flx |
| Medtronic, INC. | $172.36 | 2024-2025 | Azure Xt Dr Mri Surescan, Affera Mapping System |
| Biotronik INC. | $99.15 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $43.04 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.33 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fima Macheret listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.